Focus on Hypertension for American Heart Month: Resources for Clinicians
A number of clinical resources are available to help clinicians provide care and support for their patients with hypertension and encourage them to adopt healthy lifestyles.
All articles by Colby Stong
Eradication Testing Recommended for Patients Treated for Helicobacter pylori Infection
Improving treatment in H pylori infection could lead to better outcomes in peptic ulcer disease, gastric cancer, gastric lymphoma, and functional dyspepsia.
Low Iron Storage and Arrhythmogenic Susceptibility in Healthy Women of Childbearing Age
Low iron storage may increase arrhythmogenic susceptibility in healthy women of childbearing age.
Bacterial Infections, Severe Alcoholic Hepatitis Affect Course of Decompensated Cirrhosis
An international team of investigators conducted a multicenter, prospective, observational study to identify factors contributing to acute decompensation of cirrhosis.
Elevated Troponin and Mortality Risk in Patients Hospitalized With COVID-19
Patients who are hospitalized with COVID-19 and have an elevated vs normal troponin levels were found to be at higher risk for death.
Racial Inequities in Hypertension Treatment Intensification
Racial inequities in treatment intensification may be responsible for more than 20% of racial disparities in hypertension control.
Mavacamten May Improve LV Hypertrophy in Obstructive Hypertrophic Cardiomyopathy
Mavacamten was found to improve left ventricular hypertrophy in patients with obstructive hypertrophic cardiomyopathy.
Food Insecurity May Be Associated With Increased Cardiovascular Mortality Rates
Increases in food insecurity were found to be independently associated with increased cardiovascular mortality rates in nonelderly adults.
Healthy Lifestyle Associated With Lower All-Cause Mortality Regardless of Polypharmacy
A healthy lifestyle was found to be inversely associated with all-cause mortality, regardless of polypharmacy.
Cardiovascular Risk Among Transgender Persons Initiating Gender-Affirming Hormone Therapy
Transgender persons who present for gender-affirming hormone therapy may be at an elevated cardiovascular risk.
-
Loading...
-
Loading...
